About us
Coremine Vitae is a patient-centered biomedical company. Our wish is to give everyone the opportunity to receive personalized medicine by producing evidence-based information about the best treatment options based on the patient's profile and biomarkers.
Coremine Vitae has a broad scientific background with "state of the art" knowledge in molecular biology, biomedicine, oncology and medicine. Most of the people in our analysis team have a PhD and extensive experience from research and clinical patient care.
We have participated and are participating in a number of research projects in collaboration with leading medical environments in Norway and Europe.
The Coremine Vitae team collaborates with PubGene AS in the research project "Coremine Vitae - to identify personalized treatment options for cancer patients" where Haukeland University Hospital and Sykehuset Innlandet are partners. The research project has support from the Research Council of Norway and includes both the development of analysis tools and the implementation of Coremine Vitae analyzes for patients in order to generate information about relevant treatments.
We work closely with PubGene AS and Vitae Evidence AS, which provide complementary knowledge in bioinformatics and tool support for our medical analysts.
PhD in medicine from University of Oslo
Expertise in the field of Neuroscience and Neuro-oncology
PhD in cancer research and Molecular medicine
Expertise in cancer biology and tumor immunology
MSc. In Molecular Medicine from Trinity College, Dublin
Experience with clinical diagnostics, In-Vitro Diagnostics and cancer research
PhD in Genetics from the University of Oslo
General Surgeon and Gastrointestinal Surgeon
Head of Colorectal Unit at AHUS between 2001 and 2015
PhD from the University of Oslo
MSc Marketing Science
Over 25 years of experience in business- and product development and management
MSc Industrial Economics and Technology Management at NTNU
Former cancer patient
Master in Political Science from NTNU and UiO
Responsible for the operational strategy and implementation
Background in engineering from Venezuela
User research and product development
Professor at the Department of Pharmacology, Department of Clinical Medicine, University of Oslo
Leads the research group "Congenital lymphocytes and cancer"
Founder and managing director of the company Cellmover, which develops peptides for cellular immunotherapy.
Doctor and Medical Advisor
Over 13 years experience as a GP in England
Medical Director and General Manager of Vitae Evidence
Founded PubGene while completing his PhD.
Over 20 years of experience in bioinformatics, text mining and informatics for precision therapies.
Tor Kristian combines a technical background with supporting clinical decisions and QA for the Coremine Vitae analysts.
Professor Emerita at the University of Oslo, Oslo University Hospital and Radium Hospital.
Anne-Lise is among the leading geneticists in research into molecular biology within breast cancer.
In 2022, Anne-Lise was ranked No. 1 in Norway in research.com's selection of the best female researcher.
Anne Lise Børresen-Dale: H-index & Awards - Academic Profile | Research.com
Over 20 years of experience from private and public healthcare
Former Chief Communications Officer at Akershus University Hospital (AHUS)
Developed Helseinnovatørskolen together with UiO, NTNU and Karolinska Institutet